Pipette Quality and Management Software to Streamline Lab Processes
Artel has developed the Pipette Calibration System Software version 1.2, the latest version of its pipette quality and management software to streamline laboratory processes.
Artel, a developer of liquid handling technology, has added Pipette Calibration System (PCS) Software version 1.2, the latest version of its pipette quality and management software. According to the company, the software offers a streamlined laboratory workflow and improved overall user experience to aid in quality and compliance requirements. The system is fully compatible with the company’s first-generation PCS instruments and is integrated with the current generation of the system.
Features include pipette identification, scheduling, and reporting. The software also allows for barcode scanning of pipettes to initiate the calibration process, looking up past reports, and initiating additional pipette-related workflow directly from the home screen.
Users can schedule pipettes for calibrations and interim verifications. In addition, the software simplifies the configuration of individual pipette reports with editable fields, including company name, address, logo, accreditation logo and certificate number, and the title of the calibration or training report.
Source: Artel
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
